Funder
Japan Agency for Medical Research and Development
Japan Society for the Promotion of Science
Ministry of Education, Culture, Sports, Science and Technology
Tokyo University of Agriculture and Technology
Subject
Molecular Biology,General Medicine,Bioengineering,Biotechnology
Reference40 articles.
1. The coming of age of engineered multivalent antibodies;Nuñez-Prado;Drug Discov Today,2015
2. Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: canadian recommendations;Melosky;Curr Oncol,2009
3. New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management;on behalf of the Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group, Kroschinsky F, Stölzel F, von Bonin S, Beutel G, Kochanek M, et al;Crit Care,2017
4. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients;Abramowicz;Transplantation,1989
5. The masking game: Design of activatable antibodies and mimetics for selective therapeutics and cell control;Lucchi;ACS Cent Sci,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献